Lean NAFLD: an underrecognized and challenging disorder in medicine
- 3 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Reviews in Endocrine and Metabolic Disorders
- Vol. 22 (2), 351-366
- https://doi.org/10.1007/s11154-020-09621-1
Abstract
Classically, Non-Alcoholic Fatty Liver Disease (NAFLD) has been thought to be driven by excessive weight gain and obesity. The overall greater awareness of this disorder has led to its recognition in patients with normal body mass index (BMI). Ongoing research has helped to better understand potential causes of Lean NAFLD, the risks for more advanced disease, and potential therapies. Here we review the recent literature on prevalence, risk factors, severity of disease, and potential therapeutic interventions.Keywords
This publication has 129 references indexed in Scilit:
- Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intakeMetabolism, 2011
- Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individualsProceedings of the National Academy of Sciences of the United States of America, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisThe New England Journal of Medicine, 2010
- Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver DiseaseThe New England Journal of Medicine, 2010
- Role of Cannabinoids in the Development of Fatty Liver (Steatosis)The AAPS Journal, 2010
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver diseaseJournal of Hepatology, 2010
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeJournal of Hepatology, 2003